Agenus maintains a world footprint by collaborations and partnerships with major pharmaceutical and biotechnology organizations in North The us, Europe and Asia. Its agreements involve study and enhancement collaborations, license arrangements and co-development applications aimed at accelerating the interpretation of novel immunotherapies into med